Andrew Schwendenman

CIK: 0001977879

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

REPL

Replimune Group, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

REPL
Replimune Group, Inc.
Aug 10, 2026
Sale(S)
Direct
7.6K shares at avg. $12.97$99K
REPL
Replimune Group, Inc.
May 18, 2026
Sale(S)
Direct
7.9K shares at avg. $5.08$40K
REPL
Replimune Group, Inc.
Apr 1, 2026
Award(A)
Direct
36.7K shares-
REPL
Replimune Group, Inc.
Dec 19, 2025
Award(A)
Direct
10K shares-
REPL
Replimune Group, Inc.
May 20, 2025
Sale(S)
Direct
3.3K shares at avg. $8.05$26K
REPL
Replimune Group, Inc.
Apr 1, 2025
Award(A)
Direct
33.3K shares-

		Type	Shares	Price		Ownership
Aug 10, 2026	REPL Replimune Group, Inc.	Sale(S)	7,632	$12.97	$98,987	Direct
May 18, 2026	REPL Replimune Group, Inc.	Sale(S)	7,894	$5.08	$40,102	Direct
Apr 1, 2026	REPL Replimune Group, Inc.	Award(A)	36,667	-	$0	Direct
Dec 19, 2025	REPL Replimune Group, Inc.	Award(A)	10,000	-	-	Direct
May 20, 2025	REPL Replimune Group, Inc.	Sale(S)	3,287	$8.05	$26,460	Direct
Apr 1, 2025	REPL Replimune Group, Inc.	Award(A)	33,333	-	-	Direct

1-6 of 6 transactions

About Schwendenman Andrew

Schwendenman Andrew (SEC CIK 0001977879) files insider reports with the SEC as Chief Accounting Officer of Replimune Group, Inc. (REPL).

Signal8 holds 6 ownership filings by Schwendenman Andrew, all Form 4s, filed between Apr 3, 2025 and Aug 12, 2026. Those filings report 6 transactions, from Apr 1, 2025 to Aug 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Schwendenman Andrew's filings is in WOBURN, MA.

Recent filings by Schwendenman Andrew

Aug 10, 2026: Open-market sale of REPL shares (Form 4, code S).
May 18, 2026: Open-market sale of REPL shares (Form 4, code S).
Apr 1, 2026: Grant or award of REPL shares (Form 4, code A).
Dec 19, 2025: Grant or award of REPL shares (Form 4, code A).
May 20, 2025: Open-market sale of REPL shares (Form 4, code S).

Other insiders filing for Replimune Group, Inc. (REPL)

Astley-Sparke Philip, Director
Hill Emily Luisa, Chief Financial Officer
Patel Sushil, Chief Executive Officer
Xynos Konstantinos, Chief Medical Officer
BAKER BROS. ADVISORS LP, Director
Sarchi Christopher, Chief Commercial Officer

How to read Form 4 transaction codes